Verb Technology Company, Inc. (VERB)
Verb Technology Company, Inc. develops Software-as-a-Service applications platform in the United States, Japan, and internationally. It offers verbCRM, a customer relationship management (CRM) application; verbTEAMS, a CRM application for small and medium-sized businesses and solopreneurs; verbLEARN, a learning management system application that incorporates clickable in-video technology featured in its verbCRM application; and verbLIVE, a live eCommerce application.
Co-Diagnostics, Inc. (CODX)
Co-Diagnostics, Inc., a molecular diagnostics company, develops, manufactures, and sells reagents used for diagnostic tests that function through the detection and/or analysis of nucleic acid molecules in the United States and internationally. It offers polymerase chain reaction (PCR) diagnostic tests for COVID-19, tuberculosis, hepatitis B and C, human papilloma virus, malaria, chikungunya, dengue, and the zika virus; three multiplexed tests to test mosquitos for the identification of diseases carried by the mosquitos; and molecular tools for detection of infectious diseases, liquid biopsy for cancer screening, and agricultural applications.
Predictive Oncology Inc. (POAI)
Predictive Oncology Inc., a knowledge-driven company, focuses on developing personalized cancer therapies using artificial intelligence (AI) primarily in the United States. The company operates in four segments: Helomics, zPREDICTA, Soluble, and Skyline. The Helomics segment offers clinical testing services comprising tumor drug response testing and genomic profiling tests; and contract research services through patient-centric drug discovery using active learning technology for discovery, clinical and translational research, clinical trials, and diagnostic development and validation.
Q BioMed Inc. (QBIO)
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride SR89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, a pre-clinical lead candidate for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B for liver cancer.
QHSLab, Inc. (USAQ)
QHSLab, Inc., a medical device technology and software as a service (SaaS) company, focuses on value-based healthcare, informatics, and algorithmic personalized medicine. It also develops digital therapeutics and point of care solutions to support remote patient monitoring, address chronic care, and preventive medicine. In addition, the company provides quality health score lab expert system (QHSLab), a cloud-based SaaS system, which provides physicians and healthcare organizations with the ability to capture and store patient information electronically in a secure database; and distributes
CytoDyn Inc. (CYDY)
CytoDyn Inc. operates as a late-stage biotechnology company. The company focuses on developing treatments for multiple therapeutic indications based on leronlimab, a novel humanized monoclonal antibody targeting the CCR5 receptor. Its Leronlimab is in a class of therapeutic monoclonal antibodies designed to address unmet medical needs in the areas of human immunodeficiency virus (HIV), cancer, immunology, and novel coronavirus disease (COVID-19). The company has completed a Phase 2b pivotal trial using leronlimab in combination with antiretroviral therapies in HIV-infected treatment-experienced patients, as well as completed a Phase 2b/3 investigative trial with leronlimab as a once-weekly monotherapy for HIV-infected patients.
Voyager Digital Ltd. (VYGVF)
Voyager Digital Ltd., through its subsidiaries, operates as a crypto asset brokerage firm primarily in the United States and Canada. It operates a digital platform that enables users to buy and sell crypto assets across multiple centralized marketplaces in one account. The company was formerly known as Voyager Digital (Canada) Ltd. and changed its name to Voyager Digital Ltd. in July 2020. The company was founded in 2018 and is headquartered in New York, New York. On July 5, 2022, Voyager Digital Ltd. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the Southern District of New York. It is in joint administration with Voyager Digital Holdings, Inc.
BetterLife Pharma Inc. (BETRF)
BetterLife Pharma Inc., a biotechnology company, engages in the development and commercialization of compounds for the treatment of neurological disorders in Canada and internationally. It is involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company’s pipeline products include BETR-001 for the treatment of major depressive disorder, treatment resistance depression, cluster headaches, and post-traumatic stress disorder; and BETR-002 to treat benzodiazepine dependency, anxiety, and spasticity.
Eat Well Investment Group Inc. (EWGFF)
Eat Well Investment Group Inc. is a venture capital firm specializing in early-stage, seed and emerging growth investments. The firm seeks to invest at various stages of development, including pre-initial public offering, and/or early stage companies requiring start-up or development capital. The firm seeks to invest in agribusiness, food-tech, consumer packaged goods (CPG), plant-based and ESG (environmental, social and governance) sectors. The firm also seeks to invest in marketable securities comprising common shares and other equity instruments of companies in the mining, oil and gas, media technology, and medical technology industries that are listed on various Canadian stock exchanges or the OTCBB in the United States.
KULR Technology Group, Inc. (KULR)
KULR Technology Group, Inc., through its subsidiary, KULR Technology Corporation, develops and commercializes thermal management technologies for batteries, electronics, and other components applications in the United States. It offers lithium-ion battery thermal runaway shields; fiber thermal interface materials; phase change material heatsinks; internal short circuit device; KULR battery cell screening and testing automation system and tech safe case; cellcheck; and CRUX cathodes. The company’s technologies are used in electric vehicles, energy storage, battery recycling transportation, cloud computing, and 5G communication devices.
Transportation and Logistics Systems, Inc. (TLSS)
Transportation and Logistics Systems, Inc., through its subsidiaries, operates as a logistics and transportation company the United States. It offers ecommerce fulfillment, last mile delivery, two-person home delivery, mid-mile, and long-haul services, as well as pickup and warehousing services. As of December 31, 2021, the company owned approximately 17 vehicles, including box trucks and vans. Transportation and Logistics Systems, Inc. is based in Jupiter, Florida.